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POSSIBLE EFFECTS OF NUTRACEUTICALS IN THE MANAGEMENT OF SOME
NEURODEVELOPMENTAL DISORDERS IN NIGERIAN CHILDREN
ABSTRACT
Introduction: A nutraceutical is a pharmaceutical grade nutrient or nutrient
complex that may be used for medicinal purposes. Most nutraceuticals are
derived from plants and have been shown to be generally safe when used as
food supplements. There is growing interest in the use of these natural
products in delaying, ameliorating, and treating acute and chronic diseases.
Ong W.Y and co-editors in 2016 edited a special collection of  reports on
beneficial effects of nutraceuticals in the management of neurodegenerative
diseases and aging. However, there is paucity of  reports of  their use in sub-
Saharan Africa.
Case Reports: Here we describe a case series of some of the children managed
at our center using nutraceuticals and other supportive care. Details of the
observed effects are described in this report.
Discussion: Globally, there is rising evidence of  improved treatment
outcomes with use of nutraceuticals. Our experience in the management of
Nigerian children with neurodevelopmental disorders suggests that they
may be beneficial and are deserving of  well-controlled studies. We hope
that this case series will raise interest of researchers in Nigeria in designing
observational studies and clinical trials aimed at generating evidence for or
against their use.
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Autism spectrum disorders (ASD) are neurodevelop-
mental disorders that are characterized by varying
degrees of  impairments in psychosocial development.
They are caused by disruptions in early stages of central
nervous system development and are usually
diagnosed in the first few years of life.1 These
disorders may result from genetic mutations (or
“misreadings”) during pregnancy, maternal exposure
to infections, and other harmful elements during critical
stages of brain development. Mishaps before, at, or
shortly after delivery, and neonatal period to three years
of  age (as in the case of  autism) are other risk factors.1
Poor maternal health or inadequate access to health
care, disempowering socio-cultural and religious beliefs,
poverty, ignorance, complacency, among other reasons,
are other risk factors that may result in children being
born with defects or suffering trauma during the birth
process. These may result in irreversible brain damage
(or dysfunction) requiring a lifetime of visits to
neurologists. Conventional therapies and interventions
can be challenging and expensive with little or no
improvements in many cases. Neurologists and
pediatricians at hospitals in the Federal Capital Territory
(FCT) and all over Nigeria routinely see and manage
cases of ranging from mild to severe brain disorders,
but unfortunately see very little by way of resolution.
Patterns of  Presentation in Nigerian Children: Our Experience
at the Brain Centre (at No. 39 Suez Crescent, Abacha Estate,
Zone 4, Abuja, FCT)
Our experience (unpublished) in the management of
children with autism related conditions suggests the
following:
1. Infections, whether in-utero, or in the early stages
of life, seem to occur much more commonly
among Nigerian children than among Caucasian
children.
2. Speech seems to be much more severely affected
among Nigerian children.
3. Regardless of the cause of the neurodevelopmen-
tal condition, poor digestive system function is a
common denominator, with patients presenting
with constipation in at least 90% of  cases.
4. Nigerian parents are more apt to report that their
children display greater physical strength and have
a higher pain threshold than their peers or their
siblings at that age.
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5. Hyperactivity is more pronounced among
Nigerian children.
6. There appears to be a much later average age of
presentation in Nigerian children as opposed to
children in the western world which may be
attributable to ignorance, cultural beliefs, denial,
financial constraints, etc.
Use of Nutraceuticals
A nutraceutical is a pharmaceutical grade nutrient or
nutrient complex that may be used for medicinal
purposes. Nutraceuticals have been shown to have
health as well as nutritional benefits.2,3 The term
“nutraceutical” combines two words – “nutrient” (a
nourishing food component) and “pharmaceutical”
(a medical drug). The name was coined in 1989 by
Stephen DeFelice, founder and chairperson of  the
Foundation for Innovation in Medicine, an American
organization located in Cranford, New Jersey.
Most nutraceuticals are derived from plants and have
been shown to be generally safe when used as food
supplements. There is growing interest in the use of
these natural products in delaying, ameliorating, and
treating acute and chronic diseases. Ong W.Y and co-
editors in 2016 edited a special collection of reports
on beneficial effects of nutraceuticals in the manage-
ment of  neurodegenerative diseases and aging.4
However, there is paucity of reports of their use in
sub-Saharan Africa.
Our approach, which focuses on providing the brain
with the nutrients it requires for healing, suggests
improvement in some of the children we managed
for neurodevelopmental diseases. This paper describes
cases of children with neurodevelopmental disorders
in whom the use of nutraceuticals appear to be of
benefit. However, there remains a need for controlled
observational studies and clinical trials to verify these
preliminary observations. The objective of  this case
series is to raise interest in the use of nutraceuticals in
the treatment of children with similar neurodevelop-
mental disorders. There is also a need for controlled
clinical trials to generate evidence for the effects
described here.
CASE REPORTS
The cases presented in this paper are divided into two
segments: Autism spectrum and non-autism
neurodevelopmental disorders. The nutraceuticals used
are shown in the tables included in the descriptions.
A. Autism Spectrum Disorders
1. M.A., a 13 year old girl from Kogi State with a
severe form of  Autism
M.A. is a 13 year old girl who was referred to the
Centre with features suggestive of  severe autism –
inability to speak, limited coordination, and anti-social
tendencies. In addition to being impaired behaviourally,
she presented with these other problems: Aggression
towards siblings, she has two younger sisters, aversion
towards affection and physical contact, faecal smearing,
poor fine motor control (she could not brush her teeth
or wear clothes herself), chewing on plastic containers,
repeated bed-wetting and occasional defecating on
herself. She also displayed hyperactivity, especially in
Church (mother had to tie a rope around her to keep
Nutraceutical Dose Frequency of usage
Pure Body Drops
(Zeolites)
4 drops Three times daily
OmegaRX 2 gel capsules
(2 grams)
Twice daily
Stem Kine One capsule Twice daily
NeuroBright 2 capsules Twice daily
Probiotics One capsule Once daily
Table1: Nutraceuticals used for M.A.
her from running onto the podium and disrupting
proceedings).
She was placed on a nutraceutical regimen which
included zeolites. Within two weeks, she stopped
bedwetting, became more aware of her surroundings
and was more submissive to her parents. Most telling
was the fact that her parents no longer needed to have
restraints put on her in Church to keep her from
running around and causing commotion. Presently, she
is more sociable, sings songs on her own, responds
well to instructions, and initiates chores rather than
waits to be told to do them. She has spoken her first
word: “Hello,” and is trying to communicate more.
She however still chews on plastic containers. Recently
we were able to secure more supplements for a period
of  three months for her.
2. Miss S.A., a four-year-old girl with severe
autism
S.A. is a four-year-old girl whose parents complained
of  hyperactivity, lack of  eye contact, speech regression,
hypersensitivities and allergies, lack of coordination,
behavioral issues and difficulty in swallowing and
constipation, among others. She was initially given
nutraceuticals that work by passively removing toxins,
including heavy metals from the blood. Parents noticed
a reduction in hyperactivity, along with more
concentration, and increased attempts at speaking. At
their next visit, we expanded the treatment to include
nutraceuticals targeted at promoting apoptosis in the
brain, gut, immune and endocrine systems.
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There was significant improvement within two weeks.
Even her teachers began to notice that she was more
“settled,” paid attention in class, was more cooperative
and submissive to parents, and seemed more interested
in the world around. Her eye contact had also
improved, and she was more apt to tell her parents
whenever she wanted to use the rest room.
Constipation had also reduced. Parents are elated, but
Nutraceutical Dose Frequency of usage
Pure Body Drops (containing zeolites) Four drops Three times a day
Aroga Immune One capsule Twice daily
Aroga Endocrine One capsule Twice daily
Aroga Gut One capsule Twice daily
Aroga Brain and Nerve One capsule Twice daily
Table 2: Nutraceuticls used for Miss S.A.
finances/cost remains a factor. Parents are struggling
to keep up with treatments.
3. Miss H.A. a three-year-old girl with autism and
cerebella ataxia
H.A. was referred to our center by a pediatric
neurologist in within the city of Abuja. She presented
with an unsteady, staggering gait made worse by febrile
illnesses, causing her to fall over and hit her head
repeatedly, and a history of  frequent seizures. She also
had a history of “allergies” to certain foods (while
showing unusual preferences for others), poor
communication and socialization skills, a very limited
vocabulary, hyperactivity, “unusual strength,” a high pain
threshold, and unusual “stubbornness” along with
frequent temper tantrums. She had been diagnosed
with autism and cerebellar ataxia (a condition in the
brain responsible for the unsteady gait) by the pediatric
neurologist who referred her to us. Whenever she
attempted to walk, she would stumble and fall over
and hit her head on the ground. As a result, she had
Nutraceutical Dose Frequency of usage
Supergreens +D (mixture of probiotics and enzymes
for digestive health)
One capsule Thrice daily
Protandim (nrf2 synergizer) One caplet Once daily
Vitaloe (mannose polysaccharide complex) One scoop
(powder)
Once daily
Table3: Nutraceuticals used for Miss H.A. a three-year-old girl with autism and cerebella ataxia
multiple bumps and bruises on her forehead, which
her mother attempted to cover using a scarf.
After taking a detailed history and examination, she
was placed on nutraceuticals to heal her gut. This
included concentrates from the aloe vera plant
(supergreens) and other components as shown in the
table. After a few weeks on therapy, her mother noted
that she could take several steps without falling over,
her vocabulary and speech had improved - she was
able to pronounce new words clearer and makes
simple sentences.
According to her parents:
 “H.A. now responds well to correction if  she has done something
wrong and is scolded. She notices when her father is angry and
she says ‘sorry.’
“We have also introduced her to some kindergarten exercises
such as coloring and she is showing some interest in it.”
After another five months of taking supplements,
parents reported that:
“H.A. has been taking the supplements for almost 5 months
now and she has shown remarkable improvement. Her speech is
getting better; her balance improving every day. She falls down
less often. She doesn’t wear diapers, except when she goes to sleep
at night. She tells me when she wants to go to the toilet.
“She has started schooling also. It has been 2 months now, and
she is doing good. I am told by her teacher that she is socializing
very well with her classmates. She likes sporting activities. But
she has challenges when it comes to writing, but with time she
will be better. In sha Allah.”
It is now over three years since she first started therapy.
Parents (as well as neighbors and relatives) report steady
improvement. She is now on a single supplement for
maintenance, as parents were unable to sustain the high
monthly cost of treatment.
4. Master S.D, a six-year old boy with autism
Master S.D. is a six year old boy who was referred
from the American International School (AIS), with a
diagnosis of autism - along with inability to speak,
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hypersensitivity to sugars and gluten. He also had a
history of communication and socialization problems,
as well as hyperactivity. Following assessment, he was
placed on nutraceuticals to aid gut health (probiotics,
digestive enzymes and fermented foods) and reduce
Nutraceutical Dose Frequency of usage
Gastrex (nutrient complex for intestinal health) One capsule Thrice daily
Omega 3 fatty acid gel capsules 2 grams Twice daily
Pure body zeolite drops Four drops Three times a day
Table 4: Nutraceuticals used for Master S.D, a six-year old boy with autism
hyperactivity and aggression, and parents were
counseled on dietary restrictions.
Within two weeks, mother reported he was calmer
and paying more attention at home. Sean’s assessment
reports written by his teachers showed significant
improvement. At school, comments from his teachers
included the following (all taken from his daily reports):
“He is becoming more cooperative,”
“Started getting used to the morning routines,” “Very cooperative,
greets all the teachers, calling them by names,”
“I am very proud to say that Sean has started to follow some of
the classes’ daily routines.”
“Becoming quieter during lessons, becoming friendlier with
classmates, hugging his classmates now.”
“Has started hugging teachers and classmates, is less hyperactive.”
5. Master JWS, a 9-year-old boy from Plateau
State with a severe form of  autism
JWS’s mother contracted an untreated yeast infection
while pregnant with him. While delivery and first two
years of life were uneventful, his parents soon noticed
that he was not making any attempt to speak, displayed
hyperactivity, and would not allow others to hug or
carry him. He was later diagnosed with autism and his
mother brought him to the clinic when he was about
seven years old. We started with a series of
nutraceuticals promoting glutathione synthesis in the
body, detoxification and gut health (digestive enzymes,
probiotics, aloe vera extracts/concentrates, and
fermented foods). This was continued for about three
months. The parents observed the following
improvements: JWS became a little calmer, there was
an increase in babbling, and he was able to understand
and respond to instructions a little more.
After three months, we modified the regimen and gave
nutraceuticals for another two months. Parents noted
“a little improvement in his speech.” In their own
words:
“JWS now greets us (parents) in the morning without asking
and he now goes on errands which before he didn’t understand.
“Another improvement is that when he is called, he answers me
‘Ma’ and his dad ‘Sir.’”
 “Other noticed improvements are: he welcomes us when we get
home and does not stool on himself anymore which he occasionally
used to do.”
Nutraceutical Dose Frequency of usage
Gastrex One capsule Three times daily
Protandim One caplet Once daily
Aroga Immune One capsule Twice daily
Melatonin One capsule Once daily
Pure Body Zeolite drops Four drops Thrice daily
Table 5: Nutraceuticals used for Master J.W.S.
His parents have reported steady improvement since
the commencement of  the Nutraceuticals. He now
attempts to brush his teeth and wear his clothes himself.
These were both activities he was unable to perform
in the past. His treatment over the last three years has
been paid for by the Brain and Body Foundation (BBF).
B. Non-Autism related Neurodevelopmental
disorders
1. Miss D. A. - A 1 year old girl with Agenesis
of the Corpus Callosum
D.A. was referred from the National Hospital
physiotherapy centre with a history of limb spasms
and spasticity (including tightly clenched fists), poor
neck control, continual drooling of saliva, inability to
achieve certain physical developmental milestones (neck
control, crawling, grasping of objects), and
constipation. Examination revealed a small for age girl,
with bulging eyeballs and a “sun set” appearance,
tightly clenched fists, and spastic upper and lower limbs.
Nutraceutical Dose Frequency of
usage
Stem Kine One capsule Twice daily
NeuroBright Two capsules Twice daily
Vitaloe (powder) One scoop Once daily
OmegaRx Five mls Thrice daily
Probiotics Once capsule Once at night
Table 6: Nutraceuticals used for Miss D. A.
Magnetic resonance imaging (MRI) scan showed
complete agenesis of the corpus callosum with gross
dilatation of  the ventricles. She was placed on a series
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of nutraceuticals targeted at restoring gut health,
addressing inflammation, and improving brain function.
Within a month on these nutraceuticals, the drooling
had stopped, she started attempting to stand, had better
neck control and coordination, she showed more
liveliness and she had begun to use her left arm more.
She is now on the ninth month of therapy and has
continued to improve on the nutraceuticals.
2. Miss BAT, a ten year old girl born with severe
neurodevelopmental deficits secondary to
chromosomal deletion(46XX deletion (21) q 22.2)
Miss BAT was born at 36 weeks of gestation with a
rare deletion in a portion of a set of her chromosomes,
specifically, the 22.2 band of  the 21 st set of
chromosomes (46XX deletion (21) q 22.2). Some of
the features observed at birth included microcephally
(small head circumference), low-set ears and nipples,
“rocker-bottom feet,” and spasticity in the upper and
lower limbs. Diagnosis neurodevelopmental disorder
with chromosomal abnormality was made based on
the genetic test findings carried out at a laboratory in
Chicago, USA. The exact nature and prognosis of  the
disorder was unknown. She also had a slight heart
murmur that was expected to resolve as she grew up.
Parents were told that she would have possible
developmental delays.
Nutraceutical Dose Frequency of
usage
Gastrex One capsule Three times daily
Aroga brain and nerve One capsule Twice daily
Aroga Gut One capsule Twice daily
Aroga Immune One capsule Twice daily
Aroga Endocrine One capsule Twice daily
Table 7: Nutraceuticals used for Miss BAT
Magnetic Resonance Imaging (MRI) done at the time
of diagnosis showed cystic lesions at lateral and inferior
aspects of the left cerebellar hemisphere. Computeri-
zed Tomography (CT) and ultrasound scans showed
widespread abnormalities in the kidneys (mild
abnormality of  renal cortices), heart (biventricular
hypertrophy),
Therapy after birth: In the first year of her life, Miss
BAT had about three sets of surgeries and remained
on admission for a total of four weeks after birth. By
her eighth year, she had had occupation therapy, physical
therapy and speech therapy, all on multiple occasions.
Her speech was limited to a few words. Socially, she
was withdrawn, usually preferring to be on her own,
playing with herself, and she was severely constipated.
Our first approach at management was to administer
a nutrient formulation for improving gut health,
especially that of  the mucosal lining. Within two weeks,
her parents noted that she had improved in the number
of words she used; she danced more, seemed happier
and more relaxed, and played more often with her
two younger siblings. Socially, it seemed, she had
“opened up”. Her parents noted that she had
developed an interest in the cartoon show Tom and
Jerry, and she would “laugh so hard while watching
it.” Before then her parents said they “never really could
pinpoint a particular thing on television, for instance,
that she liked,” but now, “she shows more interest in
different things, which we are more than happy to
see.”
We then expanded her nutritional intake to include
those targeted at brain, digestive, immune and
endocrine systems repair and regulation. Within a
month, her parents saw even further improvements:
she could count from one to twenty, she added more
words to her vocabulary, could move more freely (her
movements were not as stiff), and danced more easily.
She also started to sing songs from her favorite TV
shows.
On a few occasions, her mother caught (and
videotaped) her washing her clothes, and later her
dishes, unprompted and unaided. She had never
attempted to do these before, according to her mother.
“She now tries to make sentences, though not very
audible at the moment.”
3. Miss Z.M., a five year old girl with flaccid
cerebral palsy secondary to birth trauma
Miss ZM was born on January the 10th, 2012 after a
fifteen hour labor period. She did not cry at birth,
“looked lifeless” and had to be resuscitated. Her
parents brought her to the Centre just before her
second birthday. Unfortunately, no records were
available from the previous hospital where she was
initially managed.
Nutraceutical Dose Frequency of
usage
Stem Kine One capsule Twice daily
NeuroBright Two capsules Twice daily
Vitaloe (powder) One scoop Once daily
OmegaRx Five mls Thrice daily
Probiotics One capsule Once at night
Table 8: Nutraceuticals used for Miss ZM.
We promptly placed her on a series of  nutraceuticals –
omega 3 fatty acids, a glyconutrient complex containing
the dissacharide mannose, the composite superfood
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spirulina and antioxidants – when she was about two
years. Parents noted a marked improvement after three
months of  therapy, but this could not be maintained,
as the funds were inconsistent. Presently, her parents
are in dire financial needs and progress has not been
sustained. We were able to secure nutraceuticals recently
and have since placed her on them. Within a month,
her parents noticed some significant improvement,
including increased limb activity (she now makes an
effort to move her limbs and reach for objects), and
display of positive affect and emotion. She now looks
up and smiles any time her father comes into the room,
and her neck control has improved.
4.Miss H.A., a ten year old girl with severe
neurological defects and developmental delays
According to her mother, HA’s pregnancy, delivery and
neonatal period were uneventful. On the night she
received her vaccination at nine months (measles and
Hepatitis B), her mother reports that she had a
generalized convulsion. She started drooling shortly
afterwards and stopped crawling.  She did not progress
any further for a while. She experienced delayed
developmental milestones – stood at 14 months and
walked two months later (18 months).
Speech:  She has been able to say only a few words –
“Tata” for water, and “Kelvin” for her brother. Later,
she has been able to say “daddy” and “Nana,” her
grandmother. She refers to every other person as “Vee,”
including her mother. She still has not been able to call
her mother “Mummy.”
Hyperactivity: mother notes that she became increasingly
hyperactive and agitated since the vaccination at nine
months. She has had generalized seizures since then a
total of eight times – thrice at nine months, once at 11
months and 12 months, and at 13 years. She has had
two at 14 years.
She was introduced to the Foundation in 2014, and
was promptly commenced on nutraceuticals.
Report written by mother was as follows:




Four drops Thrice daily
Table 9: Nutraceutical used for Miss H.A.
“My daughter H.A. was placed on zeolite drops for a period of
two months. She took four drops of zeolites three times daily.
During this period, I observed the following; she stopped drooling,
she began to sleep better and for longer periods, and there was
remarkable improvement in her speech. Her communication level
greatly improved and her pronunciation of words became clearer.”
In addition to the observations made by the mother
above, she has become much less hyperactive, her
teacher at school reports greater attention and
concentration. At home her mother says she now does
many chores on her own and without assistance, is
much more playful and cheerful, and sings a lot more
often now.
DISCUSSION
The uses of nutraceuticals in the cases described here
appear to have resulted in some beneficial effects.
However, well controlled studies are required to clearly
reveal the effects of nutraceuticals in these chronic,
debilitating, neurological diseases in children. Autism
spectrum disorders are multi-factorial conditions that
affect proper brain development, specifically in the
areas of  social connections, speech and behavior.
Because of  their complexity, autism spectrum disorders
can be an extremely difficult (and expensive) to treat.
A lot remains to be understood about the condition.
Treatment Challenges:
Treatment still presents a particular challenge in
developed and developing countries. One reason for
this is that, despite the huge advantages in brain research
and diagnostic technologies, little is still understood
about the condition. Unfortunately, the tools available
to clinicians for managing autism are generally limited
to drugs for controlling hyperactivity, aggression and
seizures, while symptoms such as social withdrawal
and speech deficits, those most distressing to parents,
are largely left unaddressed.
Behavioral and speech therapy are gaining greater and
greater popularity.5 They have been shown to improve
behavior (and even speech) among these children, but
therapists are in short supply in developing countries.
They tend to be drawn more to the larger, more
developed urban areas than the smaller towns and
villages, where the majority of cases are found. Further
compounding the situation are allergies, including food
and environmental allergies, increased sensitivity to
heavy metals and chemical toxins present in many of
these children.5,6 It is for these reasons that our
Foundation has decided to explore safe approaches
to alleviating the suffering of these children and
develop protocols that can be adopted by physicians
and other health care providers in the developing world.
Our Experience
Autism is not only a brain disorder; it is literally a
systemic one, affecting many cells and organs, and
systems, most especially the immune, digestive and
endocrine systems.7 Most autism-like conditions start
long before birth, during the early stages of brain
formation in the womb (first and second trimesters).
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Conditions such as maternal infections, poor diet,
exposure to heavy metals and other toxic chemicals,
and even substance (and alcohol) abuse in the mother
can all predispose to the development of autism-like
symptoms in the growing child.
Focusing on helping or strengthening the body’s ability
to do what it naturally does – repair, regulation,
detoxification – is one of the ways we have found of
dealing with complex brain disorders like autism. This
is shown in the case series described in this report.
Our experience over the years has shown that no single
agent works on its own. It takes a combination of
different nutraceuticals acting on different pathways,
organs and tissues to achieve the most benefits. One
of the keys to improvement may be the restoration
of gut health, and nutraceuticals have been shown to
support gut health.8,9
Controversies still surround the use of nutraceuticals
in the treatment of  chronic illnesses. However, evidence
seems to be mounting in support of their use. In a
systematic review by Nabavi and colleagues in 2017,
the authors concluded that growing evidence suggests
that the consumption of these compounds (nutraceuti-
cals) may represent an alternative strategy to delay the
onset and progression of depression, and depressive-
like symptoms.10 However, they stated, further
randomized and placebo-controlled trials are necessary
to confirm the potential of  these compounds as a
possible remedy for this debilitating disorder. In a
special edition on Neuronutraceuticals edited by William
RF, Moharakumar KP, and Beart PM in 2017,
contributions from experts in nutraceutical research
provided a contemporary overview of  how selected
chemically identified molecules from natural products
can beneficially affect brain function at the molecular
level.11 Contributions addressed key emergent issues
such as bioavailability, neuronal health, inflammation
and the holistic benefit of multi-targeted actions that
impact upon how nutraceuticals ultimately improve
brain function.
The evidence suggests that naturally occurring
molecules can be advantageous to both the young and
aged brain, and that they have actions that ultimately
can be directed to aid either in the improvement of
cognition or in the management of debilitating
neurodegenerative and neuropsychiatric conditions.11
Globally, literature on use of  nutraceuticals as additives
or sole agents in the management of chronic illnesses
is rising; our report provides some preliminary
observations from work done in Nigeria.
Study limitations: this report is based on clinical
observation of  the cases described. A systematic clinical
trial was not conducted. It is hoped that the case series
will raise interest for the conduction of controlled
clinical trials that will generate stronger evidence for
or against the use of nutraceuticals in Nigerian children
with neurodevelopmental disorders.
CONCLUSION
In all the cases managed at the Brain Foundation
described in this report, we added nutraceutical agents
to the therapy of  the children. These cases suggest
beneficial effects in these children and we believe the
use of  nutraceuticals described deserves further
evaluation nationwide. The cases point to the probable
efficacy of nutraceuticals in the management of the
described neurodevelopmental disorders in children.
In conclusion, more research needs to be carried out
to explore the use of nutraceuticals in larger
populations and proceed to developing effective
protocols for supporting children with
neurodevelopmental conditions.
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